Trials / Completed
CompletedNCT00003795
Quality of Life in Survivors of Gynecologic Cancer
Quality of Life of Gynecologic Cancer Survivors
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 311 (estimated)
- Sponsor
- Gynecologic Oncology Group · Network
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Quality-of-life assessment in cancer survivors may help determine the long-term effects of having had gynecologic cancer and may help improve the quality of life for future cancer survivors. PURPOSE: This clinical trial is studying the quality of life in survivors of gynecologic cancer.
Detailed description
OBJECTIVES: * Describe the significant quality of life (QOL) concerns and long term survivorship issues of women diagnosed and treated for early stage ovarian and endometrial cancer five or more years ago. * Identify mechanisms which contribute to a gynecologic cancer survivorship model through comparison and prediction of high versus low QOL associated with long term adjustment and survivorship. Examine social support, coping efforts, self-efficacy, meaning associated with survivorship, performance status, and age at diagnosis as potential predictors. * Identify and compare factors that predict high versus low QOL for women with early stage endometrial cancer completing participation in GOG-99 clinical trial. Conduct exploratory analysis examining long term QOL concerns of survivors randomized to surgery arm with or without radiotherapy. OUTLINE: Patients complete one telephone interview with a professional female interviewer. The interview lasts approximately 60 minutes and is audiotaped. PROJECTED ACCRUAL: A total of 197 early stage endometrial cancer survivors and 114 early stage ovarian cancer survivors will be accrued for this study within 2 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | quality-of-life assessment |
Timeline
- Start date
- 1999-04-01
- Primary completion
- 2002-03-01
- First posted
- 2003-07-18
- Last updated
- 2013-05-27
Locations
44 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00003795. Inclusion in this directory is not an endorsement.